UA107998C2 - Спосіб лікування, полегшення і/або попередження колоректального раку - Google Patents

Спосіб лікування, полегшення і/або попередження колоректального раку Download PDF

Info

Publication number
UA107998C2
UA107998C2 UAA201307040A UAA201307040A UA107998C2 UA 107998 C2 UA107998 C2 UA 107998C2 UA A201307040 A UAA201307040 A UA A201307040A UA A201307040 A UAA201307040 A UA A201307040A UA 107998 C2 UA107998 C2 UA 107998C2
Authority
UA
Ukraine
Prior art keywords
peg
colorectal cancer
mannitol
crc
solid
Prior art date
Application number
UAA201307040A
Other languages
English (en)
Ukrainian (uk)
Inventor
Peter Stein
Ian Cox
Samuel Smith
Leighton Jones
Jorg Plessl
Vries Corinne De
Rachel Charlton
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of UA107998C2 publication Critical patent/UA107998C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
UAA201307040A 2010-11-04 2011-04-11 Спосіб лікування, полегшення і/або попередження колоректального раку UA107998C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1018650.0A GB201018650D0 (en) 2010-11-04 2010-11-04 Methods and compositions
PCT/GB2011/001561 WO2012059725A1 (en) 2010-11-04 2011-11-04 Peg or peg block copolymers for treating colorectal cancer

Publications (1)

Publication Number Publication Date
UA107998C2 true UA107998C2 (uk) 2015-03-10

Family

ID=43414365

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201307040A UA107998C2 (uk) 2010-11-04 2011-04-11 Спосіб лікування, полегшення і/або попередження колоректального раку

Country Status (22)

Country Link
US (2) US20130216493A1 (enExample)
EP (1) EP2635289B1 (enExample)
JP (1) JP5917537B2 (enExample)
KR (1) KR20130109171A (enExample)
CN (1) CN103313719A (enExample)
AR (1) AR083770A1 (enExample)
AU (1) AU2011324996B2 (enExample)
BE (1) BE1019494A3 (enExample)
BR (1) BR112013011012A2 (enExample)
CA (1) CA2816839A1 (enExample)
EA (1) EA201300540A1 (enExample)
ES (1) ES2401269B1 (enExample)
GB (1) GB201018650D0 (enExample)
MX (1) MX349690B (enExample)
MY (1) MY163067A (enExample)
NL (1) NL2007715C2 (enExample)
NZ (1) NZ611145A (enExample)
SG (1) SG189533A1 (enExample)
TW (1) TWI606832B (enExample)
UA (1) UA107998C2 (enExample)
WO (1) WO2012059725A1 (enExample)
ZA (1) ZA201304052B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
AR093153A1 (es) * 2012-10-26 2015-05-20 Northshore Univ Healthsystem Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello
CN103083733A (zh) * 2013-02-19 2013-05-08 华熙福瑞达生物医药有限公司 一种医用体腔器械导入水性润滑剂
WO2020180581A1 (en) 2019-03-05 2020-09-10 Dow Global Technologies Llc Inducing caspase activity
US12350288B2 (en) 2019-03-05 2025-07-08 Dow Global Technologies Llc Inducing caspase activity
EP3934661B1 (en) * 2019-03-05 2025-04-02 Dow Global Technologies LLC Inducing caspase activity for treating colorectal cancer with polymers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US8457025B2 (en) * 2009-08-28 2013-06-04 Telefonaktiebolaget L M Ericsson (Publ) Method and network node for selecting a network prefix to be advertised in a communication network

Also Published As

Publication number Publication date
WO2012059725A8 (en) 2013-05-30
WO2012059725A1 (en) 2012-05-10
CN103313719A (zh) 2013-09-18
MY163067A (en) 2017-08-15
TWI606832B (zh) 2017-12-01
MX2013004963A (es) 2013-08-27
EA201300540A1 (ru) 2013-09-30
BE1019494A3 (fr) 2012-07-03
AU2011324996A1 (en) 2013-05-02
KR20130109171A (ko) 2013-10-07
AU2011324996B2 (en) 2015-10-08
ZA201304052B (en) 2014-02-26
JP5917537B2 (ja) 2016-05-18
NZ611145A (en) 2015-07-31
NL2007715A (en) 2012-05-07
US20160228467A1 (en) 2016-08-11
CA2816839A1 (en) 2012-05-10
EP2635289A1 (en) 2013-09-11
SG189533A1 (en) 2013-05-31
NL2007715C2 (en) 2012-10-16
MX349690B (es) 2017-08-09
ES2401269B1 (es) 2014-02-19
GB201018650D0 (en) 2010-12-22
AR083770A1 (es) 2013-03-20
BR112013011012A2 (pt) 2016-08-23
EP2635289B1 (en) 2020-03-11
US20130216493A1 (en) 2013-08-22
JP2013544809A (ja) 2013-12-19
TW201304785A (zh) 2013-02-01
ES2401269A1 (es) 2013-04-18

Similar Documents

Publication Publication Date Title
Kuhlemeier Epidemiology and dysphagia
Ship et al. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy‐induced dry mouth
Smidt et al. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people
Page et al. Polypharmacy and medicine regimens in older adults in residential aged care
US20160228467A1 (en) Peg or peg block copolymer for treating colorectal cancer
Kienzle-Horn et al. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation
TWI520730B (zh) 調配物
Brochier et al. Influence of dental factors on oropharyngeal dysphagia among recipients of long‐term care
IL225891A (en) Peg or block peg copolymers for the treatment of colorectal cancer
Patel Development of Novel Sustained Release Formulations for Older Adults With Swallowing Difficulties
UA108135C2 (uk) Тверда композиція для прийому всередину (варіанти), спосіб профілактики шлунково-кишкових розладів або підтримання здорового стану шлунково-кишкового тракту за її допомогою (варіанти) та упаковка, що її містить
JP2005529871A (ja) 高血圧症の予防および治療のための低用量カリウム補充
KR20210101268A (ko) 장 건강에 유익한 리보플라빈의 용도
MX2014009391A (es) Tableta de antiacido.
Tablets et al. Pr TEVA-CITALOPRAM